Literature DB >> 8417068

Quantitative analysis of elastic recoil after balloon angioplasty and after intracoronary implantation of balloon-expandable Palmaz-Schatz stents.

M Haude1, R Erbel, H Issa, J Meyer.   

Abstract

OBJECTIVES: The purpose of this study was to measure elastic recoil from sequential angiograms after balloon angioplasty and after implantation of a balloon-expandable Palmaz-Schatz stent in the same patient, and to compare the results with the late angiographic outcome.
BACKGROUND: The immediate result of coronary balloon angioplasty is influenced by plastic deformation, primarily of the atherosclerotic plaque, and by elastic recoil, primarily of the less or nondiseased vessel circumference.
METHODS: The extent of elastic recoil was measured quantitatively as the difference between maximal balloon size and the resulting vessel diameter or cross-sectional area.
RESULTS: Analysis was performed in 60 patients who received a single stent for late restenosis after initially successful coronary balloon angioplasty. Minimal lumen diameter (minimal cross-sectional area) was 0.98 +/- 0.43 mm (0.97 +/- 0.67 mm2) before balloon angioplasty, 2.06 +/- 0.36 mm (3.68 +/- 1.17 mm2) after angioplasty (both p < 0.001 vs. values before angioplasty) and 2.98 +/- 0.26 mm (7.12 +/- 1.28 mm2) after stenting (both p < 0.001 vs. postangioplasty results). No significant changes in vessel reference diameters or areas were measured. Mean balloon/artery ratios were similar in both procedures, ranging from 0.93 to 0.96. The calculated mean elastic recoil was 0.98 +/- 0.50 mm in diameter (31%) and 3.67 +/- 2.05 mm2 in area (48%) after balloon angioplasty compared with 0.10 +/- 0.07 mm (3.5%) and 0.38 +/- 0.36 mm2 (5.1%) after stenting. Increasing balloon sizes induced increased vessel stretch, which was followed by increased elastic recoil in the angioplasty group in contrast to the stenting group. Short, noncalcified and eccentric lesions tend to be associated with increased recoil after balloon angioplasty. Overdilation or underdilation in one of the procedures, changes in postprocedural vasomotion or postprocedural thrombus formation was not responsible for this outcome. After 6 months mean minimal lumen diameter was 2.39 +/- 0.58 mm, suggesting a mean hyperplasia of 0.59 +/- 0.51 mm. Twelve patients (20%) had a follow-up diameter that was equal to or less than the mean postangioplasty result and eight patients (14%) had a diameter stenosis of > 50%.
CONCLUSIONS: The implantation of a Palmaz-Schatz stent almost completely eliminates the decrease in vessel dimensions caused by elastic recoil and therefore diminishes the impact of hyperplasia and reduces the rate of restenosis.

Entities:  

Mesh:

Year:  1993        PMID: 8417068     DOI: 10.1016/0735-1097(93)90713-b

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  21 in total

1.  Early lumen diameter loss after percutaneous transluminal coronary angioplasty is related to coronary plaque burden: a role for viscous plaque properties in early lumen diameter loss.

Authors:  W E Kok; R J Peters; G Pasterkamp; R A van Liebergen; J J Piek; K T Koch; C A Visser
Journal:  Int J Cardiovasc Imaging       Date:  2001-04       Impact factor: 2.357

2.  Mechanism of lumen enlargement with direct stenting versus predilatation stenting: influence of remodelling and plaque characteristics assessed by volumetric intracoronary ultrasound.

Authors:  G Finet; N J Weissman; G S Mintz; L F Satler; K M Kent; J R Laird; G A Adelmann; A E Ajani; M T Castagna; G Rioufol; A D Pichard
Journal:  Heart       Date:  2003-01       Impact factor: 5.994

3.  Small vessel stents for intracranial angioplasty: in vitro evaluation of in-stent stenoses using CT angiography.

Authors:  M Trossbach; M Hartmann; C Braun; K Sartor; S Hähnel
Journal:  Neuroradiology       Date:  2004-05-01       Impact factor: 2.804

4.  Tissue Doppler imaging (TDI) for on-line detection of regional early diastolic ventricular asynchrony in patients with coronary artery disease.

Authors:  C Bruch; A Schmermund; T Bartel; J Schaar; R Erbel
Journal:  Int J Card Imaging       Date:  1999-10

5.  Selective deposits of versican in the extracellular matrix of restenotic lesions from human peripheral arteries.

Authors:  T N Wight; S Lara; R Riessen; R Le Baron; J Isner
Journal:  Am J Pathol       Date:  1997-10       Impact factor: 4.307

Review 6.  Endovascular stents: a 'break through technology', future challenges.

Authors:  A G Violaris; Y Ozaki; P W Serruys
Journal:  Int J Card Imaging       Date:  1997-02

7.  Preventable effects of bare-metal stent on restenosis after everolimus-eluting stent deployment.

Authors:  Akihiro Shirakabe; Masamichi Takano; Masanori Yamamoto; Osamu Kurihara; Nobuaki Kobayashi; Masato Matsushita; Masafumi Tsurumi; Hirotake Okazaki; Noritake Hata; Wataru Shimizu
Journal:  Heart Vessels       Date:  2014-10-21       Impact factor: 2.037

8.  Predictors of acute scaffold recoil after implantation of the everolimus-eluting bioresorbable scaffold: an optical coherence tomography assessment in native coronary arteries.

Authors:  Takao Sato; John Jose; Mohamed El-Mawardy; Dmitriy S Sulimov; Ralph Tölg; Gert Richardt; Mohamed Abdel-Wahab
Journal:  Int J Cardiovasc Imaging       Date:  2016-10-19       Impact factor: 2.357

9.  In vivo assessment of stent recoil of biodegradable polymer-coated cobalt-chromium sirolimus-eluting coronary stent system.

Authors:  Atul D Abhyankar; Ashok S Thakkar
Journal:  Indian Heart J       Date:  2012-07-27

Review 10.  The role of glucose lowering agents on restenosis after percutaneous coronary intervention in patients with diabetes mellitus.

Authors:  Chris P H Lexis; Braim M Rahel; Joan G Meeder; Felix Zijlstra; Iwan C C van der Horst
Journal:  Cardiovasc Diabetol       Date:  2009-07-28       Impact factor: 9.951

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.